The most frequently mutated genes in the luminal breast cancer TCGA cohort included PIK3CA, TP53, CDH1, and GATA3 mutated in 42.5%, 17.8%, 16.9%, and 16.8% of cases, respectively. This evidence concerns the gene TP53 and breast carcinoma.